South Korea · Delayed Price · Currency is KRW SG HealthCare Statistics
Total Valuation
SG HealthCare has a market cap or net worth of KRW 26.48 billion. The enterprise value is 29.49 billion.
| Market Cap | 26.48B |
| Enterprise Value | 29.49B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SG HealthCare has 11.51 million shares outstanding. The number of shares has increased by 39.00% in one year.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | +39.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.81% |
| Owned by Institutions (%) | n/a |
| Float | 8.08M |
Valuation Ratios
The trailing PE ratio is 23.63.
| PE Ratio | 23.63 |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | 19.56 |
| P/OCF Ratio | 11.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.15, with an EV/FCF ratio of 21.79.
| EV / Earnings | 26.78 |
| EV / Sales | 1.14 |
| EV / EBITDA | 12.15 |
| EV / EBIT | 18.11 |
| EV / FCF | 21.79 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.94 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 3.22 |
| Debt / FCF | 5.74 |
| Interest Coverage | 4.37 |
Financial Efficiency
Return on equity (ROE) is 4.49% and return on invested capital (ROIC) is 4.38%.
| Return on Equity (ROE) | 4.49% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 4.38% |
| Return on Capital Employed (ROCE) | 6.23% |
| Weighted Average Cost of Capital (WACC) | 3.29% |
| Revenue Per Employee | 683.05M |
| Profits Per Employee | 28.98M |
| Employee Count | 38 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 2.67 |
Taxes
In the past 12 months, SG HealthCare has paid 300.14 million in taxes.
| Income Tax | 300.14M |
| Effective Tax Rate | 22.08% |
Stock Price Statistics
The stock price has decreased by -25.32% in the last 52 weeks. The beta is -0.20, so SG HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -25.32% |
| 50-Day Moving Average | 1,971.42 |
| 200-Day Moving Average | 2,877.80 |
| Relative Strength Index (RSI) | 68.95 |
| Average Volume (20 Days) | 71,156 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SG HealthCare had revenue of KRW 25.96 billion and earned 1.10 billion in profits. Earnings per share was 97.33.
| Revenue | 25.96B |
| Gross Profit | 8.20B |
| Operating Income | 1.61B |
| Pretax Income | 1.36B |
| Net Income | 1.10B |
| EBITDA | 2.41B |
| EBIT | 1.61B |
| Earnings Per Share (EPS) | 97.33 |
Balance Sheet
The company has 5.18 billion in cash and 7.77 billion in debt, with a net cash position of -2.59 billion or -225.25 per share.
| Cash & Cash Equivalents | 5.18B |
| Total Debt | 7.77B |
| Net Cash | -2.59B |
| Net Cash Per Share | -225.25 |
| Equity (Book Value) | 25.16B |
| Book Value Per Share | 2,153.09 |
| Working Capital | 11.93B |
Cash Flow
In the last 12 months, operating cash flow was 2.26 billion and capital expenditures -905.31 million, giving a free cash flow of 1.35 billion.
| Operating Cash Flow | 2.26B |
| Capital Expenditures | -905.31M |
| Depreciation & Amortization | 799.28M |
| Net Borrowing | 2.05B |
| Free Cash Flow | 1.35B |
| FCF Per Share | 117.58 |
Margins
Gross margin is 31.60%, with operating and profit margins of 6.21% and 4.24%.
| Gross Margin | 31.60% |
| Operating Margin | 6.21% |
| Pretax Margin | 5.24% |
| Profit Margin | 4.24% |
| EBITDA Margin | 9.29% |
| EBIT Margin | 6.21% |
| FCF Margin | 5.21% |
Dividends & Yields
SG HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -39.00% |
| Shareholder Yield | -39.00% |
| Earnings Yield | 4.16% |
| FCF Yield | 5.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.3285691.
| Last Split Date | Dec 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.3285691 |
Scores
SG HealthCare has an Altman Z-Score of 6.57 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.57 |
| Piotroski F-Score | 6 |